Category: CovidienSyndicate content

Covidien recalls Trellis clot-busting devices on labeling snafu

February 11, 2015 by Brad Perriello

A labeling miscue prompts Covidien to recall 2 models of its Trellis clot-busting infusion device.

Covidien recalls Trellis clot-busting devices on labeling snafu

UPDATED Feb. 12, 2015, with new information from Medtronic.

Strong 5-year data for Medtronic's ClosureFast varicose vein device

February 10, 2015 by Brad Perriello

Results from a study of Medtronic's ClosureFast varicose vein device, published this month in the British Journal of Surgery, show an 91.9% occlusion rate after 5 years.

Strong 5-year data for Medtronic's ClosureFast varicose vein device

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Regulators deal WMGI double whammy | Regulatory news for the week of February 9, 2015

February 10, 2015 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: Regulators deal Wright Medical a double whammy; Medtronic wins FDA approval for Melody pulmonary valve; FDA approves Cohera's TissuGlu surgical sealant; FDA approves Medtronic's Pipeline Flex aneurysm device; Sorin wins MRI-safe pacemaker approval in Japan

Regulators deal Wright Medical a double whammy

February 3, 2015 by Brad Perriello

Medtronic's new Ev3 unit pays $1.3m in whistleblower suit

February 6, 2015 by Brad Perriello

Medtronic agrees to settle for $1.25 million a whistleblower lawsuit inherited from the Ev3 subsidiary it acquired in the $50 billion Covidien deal.

Medtronic's new Ev3 unit pays $1.3m in whistleblower suit

FDA approves Medtronic's Pipeline Flex aneurysm device

February 5, 2015 by Brad Perriello

The FDA grants pre-market approval for the Pipeline Flex device for treating brain aneurysms Medtronic acquired along with Covidien.

FDA approves Medtronic's Pipeline Flex aneurysm device

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

St. Jude CEO Starks: It's the size of the market, not the company that matters

February 2, 2015 by Brian Johnson

St. Jude Medical CEO Daniel Starks tells analysts that the medical device company doesn't need to follow it's competitors down the path of consolidation.

St. Jude CEO Starks: It's the size of the market, not the company that matters

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Asante Solutions sets terms for pending IPO | Medtech Wall Street news for the week of January 26, 2015

January 29, 2015 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: Asante Solutions sets IPO terms; Stryker CEO Lobo: M&A is our top priority for cash; Abiomed surges on Q3 numbers, FDA nod; Credit agencies lower Medtronic's rating post-Covidien merger

Diabetes: Asante Solutions sets IPO terms

January 23, 2015 by Brad Perriello